Dinaciclib, a Cyclin-Dependent Kinase Inhibitor Promotes Proteasomal Degradation of Mcl-1 and Enhances ABT-737-Mediated Cell Death in Malignant Human Glioma Cell Lines. - Jane EP; Premkumar DR; Cavaleri JM; Sutera PA; Rajasekar T; Pollack IF (The Journal of pharmacology and experimental therapeutics, 2016)